157 related articles for article (PubMed ID: 26268879)
1. ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3).
Markt SC; Shui IM; Unger RH; Urun Y; Berg CD; Black A; Brennan P; Bueno-de-Mesquita HB; Gapstur SM; Giovannucci E; Haiman C; Henderson B; Hoover RN; Hunter DJ; Key TJ; Khaw KT; Canzian F; Larranga N; Le Marchand L; Ma J; Naccarati A; Siddiq A; Stampfer MJ; Stattin P; Stevens VL; Stram DO; Tjønneland A; Travis RC; Trichopoulos D; Ziegler RG; Lindstrom S; Kraft P; Mucci LA; Choueiri TK; Wilson KM
Prostate; 2015 Nov; 75(15):1677-81. PubMed ID: 26268879
[TBL] [Abstract][Full Text] [Related]
2. A genome-wide pleiotropy scan for prostate cancer risk.
Panagiotou OA; Travis RC; Campa D; Berndt SI; Lindstrom S; Kraft P; Schumacher FR; Siddiq A; Papatheodorou SI; Stanford JL; Albanes D; Virtamo J; Weinstein SJ; Diver WR; Gapstur SM; Stevens VL; Boeing H; Bueno-de-Mesquita HB; Barricarte Gurrea A; Kaaks R; Khaw KT; Krogh V; Overvad K; Riboli E; Trichopoulos D; Giovannucci E; Stampfer M; Haiman C; Henderson B; Le Marchand L; Gaziano JM; Hunter DJ; Koutros S; Yeager M; Hoover RN; ; Chanock SJ; Wacholder S; Key TJ; Tsilidis KK
Eur Urol; 2015 Apr; 67(4):649-57. PubMed ID: 25277271
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.
Wolpin BM; Kraft P; Gross M; Helzlsouer K; Bueno-de-Mesquita HB; Steplowski E; Stolzenberg-Solomon RZ; Arslan AA; Jacobs EJ; Lacroix A; Petersen G; Zheng W; Albanes D; Allen NE; Amundadottir L; Anderson G; Boutron-Ruault MC; Buring JE; Canzian F; Chanock SJ; Clipp S; Gaziano JM; Giovannucci EL; Hallmans G; Hankinson SE; Hoover RN; Hunter DJ; Hutchinson A; Jacobs K; Kooperberg C; Lynch SM; Mendelsohn JB; Michaud DS; Overvad K; Patel AV; Rajkovic A; Sanchéz MJ; Shu XO; Slimani N; Thomas G; Tobias GS; Trichopoulos D; Vineis P; Virtamo J; Wactawski-Wende J; Yu K; Zeleniuch-Jacquotte A; Hartge P; Fuchs CS
Cancer Res; 2010 Feb; 70(3):1015-23. PubMed ID: 20103627
[TBL] [Abstract][Full Text] [Related]
4. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium.
Wolpin BM; Kraft P; Xu M; Steplowski E; Olsson ML; Arslan AA; Bueno-de-Mesquita HB; Gross M; Helzlsouer K; Jacobs EJ; LaCroix A; Petersen G; Stolzenberg-Solomon RZ; Zheng W; Albanes D; Allen NE; Amundadottir L; Austin MA; Boutron-Ruault MC; Buring JE; Canzian F; Chanock SJ; Gaziano JM; Giovannucci EL; Hallmans G; Hankinson SE; Hoover RN; Hunter DJ; Hutchinson A; Jacobs KB; Kooperberg C; Mendelsohn JB; Michaud DS; Overvad K; Patel AV; Sanchéz MJ; Sansbury L; Shu XO; Slimani N; Tobias GS; Trichopoulos D; Vineis P; Visvanathan K; Virtamo J; Wactawski-Wende J; Watters J; Yu K; Zeleniuch-Jacquotte A; Hartge P; Fuchs CS
Cancer Epidemiol Biomarkers Prev; 2010 Dec; 19(12):3140-9. PubMed ID: 20971884
[TBL] [Abstract][Full Text] [Related]
5. PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).
Dossus L; Kaaks R; Canzian F; Albanes D; Berndt SI; Boeing H; Buring J; Chanock SJ; Clavel-Chapelon F; Feigelson HS; Gaziano JM; Giovannucci E; Gonzalez C; Haiman CA; Hallmans G; Hankinson SE; Hayes RB; Henderson BE; Hoover RN; Hunter DJ; Khaw KT; Kolonel LN; Kraft P; Ma J; Le Marchand L; Lund E; Peeters PH; Stampfer M; Stram DO; Thomas G; Thun MJ; Tjonneland A; Trichopoulos D; Tumino R; Riboli E; Virtamo J; Weinstein SJ; Yeager M; Ziegler RG; Cox DG
Carcinogenesis; 2010 Mar; 31(3):455-61. PubMed ID: 19965896
[TBL] [Abstract][Full Text] [Related]
6. ABO blood group alleles and the risk of pancreatic cancer in a Japanese population.
Nakao M; Matsuo K; Hosono S; Ogata S; Ito H; Watanabe M; Mizuno N; Iida S; Sato S; Yatabe Y; Yamao K; Ueda R; Tajima K; Tanaka H
Cancer Sci; 2011 May; 102(5):1076-80. PubMed ID: 21306478
[TBL] [Abstract][Full Text] [Related]
7. ABO blood group and breast cancer incidence and survival.
Gates MA; Xu M; Chen WY; Kraft P; Hankinson SE; Wolpin BM
Int J Cancer; 2012 May; 130(9):2129-37. PubMed ID: 21633955
[TBL] [Abstract][Full Text] [Related]
8. Association of ABO polymorphisms and pancreatic Cancer/ Cardiocerebrovascular disease: a meta-analysis.
Li Y; Liu L; Huang Y; Zheng H; Li L
BMC Med Genet; 2020 Feb; 21(1):41. PubMed ID: 32093636
[TBL] [Abstract][Full Text] [Related]
9. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Chen YC; Kraft P; Bretsky P; Ketkar S; Hunter DJ; Albanes D; Altshuler D; Andriole G; Berg CD; Boeing H; Burtt N; Bueno-de-Mesquita B; Cann H; Canzian F; Chanock S; Dunning A; Feigelson HS; Freedman M; Gaziano JM; Giovannucci E; Sánchez MJ; Haiman CA; Hallmans G; Hayes RB; Henderson BE; Hirschhorn J; Kaaks R; Key TJ; Kolonel LN; LeMarchand L; Ma J; Overvad K; Palli D; Pharaoh P; Pike M; Riboli E; Rodriguez C; Setiawan VW; Stampfer M; Stram DO; Thomas G; Thun MJ; Travis RC; Virtamo J; Trichopoulou A; Wacholder S; Weinstein SJ
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1973-81. PubMed ID: 17932344
[TBL] [Abstract][Full Text] [Related]
10. Association study between common variations in some candidate genes and prostate adenocarcinoma predisposition through multi-stage approach in Iranian population.
Beikzadeh B; Angaji SA; Abolhasani M
BMC Med Genet; 2020 Apr; 21(1):81. PubMed ID: 32295536
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study.
Antwi SO; Bamlet WR; Pedersen KS; Chaffee KG; Risch HA; Shivappa N; Steck SE; Anderson KE; Bracci PM; Polesel J; Serraino D; La Vecchia C; Bosetti C; Li D; Oberg AL; Arslan AA; Albanes D; Duell EJ; Huybrechts I; Amundadottir LT; Hoover R; Mannisto S; Chanock SJ; Zheng W; Shu XO; Stepien M; Canzian F; Bueno-de-Mesquita B; Quirós JR; Zeleniuch-Jacquotte A; Bruinsma F; Milne RL; Giles GG; Hébert JR; Stolzenberg-Solomon RZ; Petersen GM
Carcinogenesis; 2018 Jul; 39(8):1056-1067. PubMed ID: 29800239
[TBL] [Abstract][Full Text] [Related]
12. Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.
Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippmann SM; Parnes HL; Dluzniewski PJ; Isaacs WB; De Marzo AM; Drake CG; Platz EA
Prostate; 2015 Sep; 75(13):1403-18. PubMed ID: 26047319
[TBL] [Abstract][Full Text] [Related]
13. Re-evaluation of ABO gene polymorphisms detected in a genome-wide association study and risk of pancreatic ductal adenocarcinoma in a Chinese population.
Xu HL; Cheng JR; Zhang W; Wang J; Yu H; Ni QX; Risch HA; Gao YT
Chin J Cancer; 2014 Feb; 33(2):68-73. PubMed ID: 23816557
[TBL] [Abstract][Full Text] [Related]
14. TRPV6 alleles do not influence prostate cancer progression.
Kessler T; Wissenbach U; Grobholz R; Flockerzi V
BMC Cancer; 2009 Oct; 9():380. PubMed ID: 19857260
[TBL] [Abstract][Full Text] [Related]
15. Blood groups A and AB are associated with increased gastric cancer risk: evidence from a large genetic study and systematic review.
Mao Y; Yang W; Qi Q; Yu F; Wang T; Zhang H; Dai J; Ma H; Hu Z; Shen H; Li G; Jin G
BMC Cancer; 2019 Feb; 19(1):164. PubMed ID: 30791881
[TBL] [Abstract][Full Text] [Related]
16. Association study of polymorphisms in the ABO gene and their gene-gene interactions with ischemic stroke in Chinese population.
Li H; Cai Y; Xu AD
J Clin Lab Anal; 2018 May; 32(4):e22329. PubMed ID: 28984382
[TBL] [Abstract][Full Text] [Related]
17. Variation at ABO histo-blood group and FUT loci and diffuse and intestinal gastric cancer risk in a European population.
Duell EJ; Bonet C; Muñoz X; Lujan-Barroso L; Weiderpass E; Boutron-Ruault MC; Racine A; Severi G; Canzian F; Rizzato C; Boeing H; Overvad K; Tjønneland A; Argüelles M; Sánchez-Cantalejo E; Chamosa S; Huerta JM; Barricarte A; Khaw KT; Wareham N; Travis RC; Trichopoulou A; Trichopoulos D; Yiannakouris N; Palli D; Agnoli C; Tumino R; Naccarati A; Panico S; Bueno-de-Mesquita HB; Siersema PD; Peeters PH; Ohlsson B; Lindkvist B; Johansson I; Ye W; Johansson M; Fenger C; Riboli E; Sala N; González CA
Int J Cancer; 2015 Feb; 136(4):880-93. PubMed ID: 24947433
[TBL] [Abstract][Full Text] [Related]
18. ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium.
Poole EM; Gates MA; High BA; Chanock SJ; Cramer DW; Cunningham JM; Fridley BL; Gayther SA; Goode EL; Iversen ES; Lissowska J; Palmieri Weber RT; Pharoah PD; Phelan CM; Ramus SJ; Schildkraut JM; Sutphen R; Tsai YY; Tyrer J; Vierkant RA; Wentzensen N; Yang HP; Terry KL; Tworoger SS
Cancer Causes Control; 2012 Nov; 23(11):1805-10. PubMed ID: 22961099
[TBL] [Abstract][Full Text] [Related]
19. Relationship between ABO Blood Group Alleles and Pancreatic Cancer Is Modulated by Secretor (FUT2) Genotype, but Not Lewis Antigen (FUT3) Genotype.
Kim J; Yuan C; Amundadottir LT; Wolpin BM; ; Klein AP; ; Risch HA; Kraft P
Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1242-1248. PubMed ID: 37342060
[TBL] [Abstract][Full Text] [Related]
20. Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk.
Cooper ML; Adami HO; Grönberg H; Wiklund F; Green FR; Rayman MP
Cancer Res; 2008 Dec; 68(24):10171-7. PubMed ID: 19074884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
